Skip to main content


Register for Moving Beyond the Barriers

Moving Beyond the Barriers of Treating OUD - OB/GYN Focus

Tuesday, July 20, 2021
5:30 pm - 8:30 pm ET

This OB/GYN focused course is made available in part through grant funding from the CDC and in partnership with ACOG. Click here to learn more about the ASAM-ACOG partnership and offerings.

Overview

You already have your waiver—now what? This FREE interactive and engaging virtual-live course addresses moving beyond common barriers that prevent DEA-waivered clinicians from successfully implementing office-based treatment for patients with opioid use disorder. This OB/GYN-focused course is made available in part through grant funding from the CDC and in partnership with ACOG

This course is separate from The Review Course and is not included in the Full Course registration.

Who Should Attend

Healthcare providers who have not yet implemented their waiver or providers who face barriers to implementing their waiver.

Learning Objectives

  1. Recognize common barriers and challenges to implementing treatment of OUD.
  2. Apply evidence-based practices to overcome obstacles to treatment of OUD.
  3. Identify strategies to meet patient care needs with available resources to ensure continuity of care.

Speakers

  • Alta DeRoo, MD, FASAM, FACOG
    Dr. Alta DeRoo has been an attending physician at Naval Medical Center San Diego, Walter Reed National Military Medical Center, Naval Hospital Camp Lejeune, and University of Virginia School of Medicine. She is currently the director of OBGYN at University of Virginia – Culpeper and an associate professor at the University of Virginia School of Medicine. Dr. DeRoo is board certified by the American Board of Addiction Medicine (ABAM), as well as by the American Board of Obstetrics and Gynecology. She is a contributor to publications regarding opioid use disorders among pregnant women and lectures frequently on addiction medicine topics.

    Dr. DeRoo specializes in treating pregnant women with opioid use disorders and leads an Office Based Opioid Treatment program (OBOT) in Culpeper, VA. She is the regional clinical champion for the education of physicians regarding buprenorphine waiver training for the state of Virginia. She is also the secretary for the Virginia Chapter of the American Society of Addiction Medicine.
  • Kirk Moberg, MD, PhD, DFASAM, FACP, FACPE, CPE
    Dr. Kirk Moberg is a graduate of and Clinical Professor of Internal Medicine and Psychiatry at the University of Illinois College of Medicine. Trained in Internal Medicine he practiced in the field of Addiction Medicine for over 25 years and served as medical director of three addiction treatment centers. He is certified by both the American Board of Internal Medicine and the American Board of Preventive Medicine-Addiction Medicine and is certified as a Medical Review Officer.
  • Tricia Wright, MD, MS, FACOG, DFASAM
    Tricia Wright, MD MS is a Professor of Clinical Medicine in the Department of Obstetrics, Gynecology and Reproductive Health at the University of California, San Francisco. Previously she was at the University of Hawaii and founded the Path Clinic, a perinatal clinic specializing in the care of pregnant and parenting women with Substance Use Disorders. She is board certified in both Obstetrics and Gynecology and Addiction Medicine and a Fellow of the American College of Obstetrics and Gynecology and a Distinguished Fellow of the American Society of Addiction Medicine. She has published multiple papers on pregnancy and addiction as well as a textbook Opioid Use Disorders in Pregnancy published in 2018 by Cambridge University Press.

    Dr. Wright completed her undergraduate degree in Biological Sciences from Stanford University, her MD from the University of Michigan. She completed her residency in Obstetrics and Gynecology from the University of New Mexico and obtained a Master’s Degree in Clinical Research from the University of Hawai‘i.

Credits & Maintenance of Certification

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Family Physicians (AAFP)
The AAFP has reviewed The ASAM Virtual Review PreCourse: Moving Beyond the Barriers of Treating Opioid Use Disorder and deemed it acceptable for up to 2.50 In-Person, Live (could include online) AAFP Prescribed credit. Term of Approval is from 07/20/2021 to 07/20/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222.

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222.

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

American Board of Medical Specialties (ABMS) MOC Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Moving Beyond the Barriers of Treating Opioid Use Disorder has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: Anesthesiology, Family Medicine, Physical Medicine and Rehabilitation, Preventive Medicine, Psychiatry and Neurology, Radiology.

American Board of Preventive Medicine (ABPM)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 2.5 LLSA credits towards ABPM MOC Part II requirements.

American Board of Anesthesiology (ABA)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

American Board of Pediatrics (ABP)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 2.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program. 

American Board of Addiction Medicine (ABAM)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

Royal College of Physicians and Surgeons of Canada (RCPSC)
Royal College Fellows can use participation in Accredited Continuing Medical Education to earn Section 3 Credits.

CME Committee, Program Planning Committee, and Faculty Disclosure Information
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.